RDH11 Antibodies

Santa Cruz Biotechnology features a diverse variety of RDH11 monoclonal antibodies for advanced research in molecular biology. RDH11 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RDH11, or Retinol Dehydrogenase 11, plays a crucial role in the metabolism of retinoids, which are essential for vision, cellular differentiation, and embryonic development. By converting all-trans-retinol to 11-cis-retinal, RDH11 is vital for the regeneration of visual pigments in the retina, making it a key player in maintaining proper visual function. Additionally, RDH11 is implicated in various physiological processes, highlighting its significance in both health and disease. Understanding RDH11's function and regulation can provide valuable insights into retinal disorders and potential therapeutic approaches. Investigating RDH11's role in cellular processes may reveal new pathways and mechanisms in visual system development. RDH11 research continues to expand our knowledge of retinoid metabolism and its impact on human health. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of RDH11 and its role in vision and development.